Genzyme (GENZ) Confirms Issues Discussed in Presentation This Morning: $89/Share Estimate, Q4, FY11 Outlook
Tweet Send to a Friend
Genzyme (Nasdaq: GENZ) has just issued a press release confirmed the topics that were disclosed during ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


